Document ID: chunk:federal_register_of_legislation:F2022L00269:reg:8
Version: federal_register_of_legislation:F2022L00269
Segment Type: reg
Provision Reference: reg 8
Character Range: 4377–5352

8               Factors that must exist
At least one of the following factors must exist before it can be said that, on the balance of probabilities, vaccine-induced thrombotic thrombocytopaenia or death from vaccine-induced thrombotic thrombocytopaenia is connected with the circumstances of a person's relevant service:
(1)           having received an adenovirus vector coronavirus disease 2019 (COVID-19) vaccine within the 100 days before the clinical onset of vaccine-induced thrombotic thrombocytopaenia;
Note: Examples of adenovirus vector COVID-19 vaccines include:

                (a)             Ad26.COV2.S (Janssen COVID-19 Vaccine);
                (b)            ChAdOx1 nCoV-19 (Vaxevria, Oxford/Astra-Zeneca);
                (c)             Gam-COVID-Vac (Sputnik V, Sputnik Light); and
                (d)            AD5-nCOV (Convidecia).
(2)          inability to obtain appropriate clinical management for vaccine-induced thrombotic thrombocytopaenia.